News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech FivePrime Therapeutics, Inc. Files for a $60 Million IPO



7/30/2013 7:28:48 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Five Prime Therapeutics, an early clinical stage biotech developing protein therapeutics, filed on Friday with the SEC to raise up to $60 million in an initial public offering. Its backers include Pfizer (13.7% pre-IPO stake), Advanced Technology Ventures (9.1%), Domain Associates (9.1%), HealthCap (9.1%), KPCB (9.1%), Texas Pacific Group (9.1%), Versant Ventures (9.1%) and GSK (6.3%).

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES